Opens in a new tab

Duffy-Null Neutrophil Count: New Normal Ranges for Adults and Children

Table of Content

Blood tube and CBC report with a white blood cell count, illustrating new Duffy null neutrophil reference ranges

⚕️ This article is for informational purposes only and does not replace medical advice. Always consult your doctor to interpret your results.

Has a blood test ever flagged your neutrophils or white blood cells as low, even though you felt perfectly healthy? For millions of Americans, the explanation is a harmless inherited trait called Duffy null. On November 5, 2026, the American Society of Hematology (ASH) journal Blood Advances published the first Duffy-null reference ranges for children, along with a large check of the adult ranges. Here is what the study found, what it means for reading your complete blood count (CBC), and which questions to ask your doctor.

What does Duffy null mean?

Duffy is a blood group system, like ABO or Rh, though far less familiar. It refers to a protein found on the surface of red blood cells. In people who are Duffy null, written Fy(a-b-), a small change in the ACKR1 gene keeps that protein off the red cells. The variant is very common in people with African ancestry, and it protects against one type of malaria. The researchers estimate that about 10% of the US population is Duffy null.

The trait's most visible effect in the lab is a lower count of neutrophils circulating in the blood, without more infections. A large genetic study across three US biobanks, including All of Us and the Million Veteran Program, found that Duffy-null status was consistently linked only to lower white blood cell counts, not to any disease. Experts now call this pattern Duffy null-associated neutrophil count, or DANC, instead of the older term "benign ethnic neutropenia."

What the new study found

Researchers at 23 US sites, led by hematologist Lauren Merz and colleagues, enrolled 1,412 healthy people with confirmed Duffy-null status, from 6 months of age to adulthood. Using standard laboratory guidelines, they calculated the ranges where these people's absolute neutrophil count (ANC) and white blood cell count (WBC) normally fall.

Age groupANC (×10⁹/L)WBC (×10⁹/L)
6 months to 2 years0.53 to 4.504.4 to 12.6
3 to 6 years0.78 to 4.673.8 to 10.8
7 to 12 years0.87 to 5.342.9 to 10.1
13 to 17 years0.90 to 4.893.1 to 9.2
Adults (18 and older)1.03 to 7.303.0 to 10.7

Ranges proposed by Merz and colleagues (Blood Advances, 2026) for healthy Duffy-null people. On many US lab reports, 1.03 ×10⁹/L appears as 1,030 cells per microliter or 1.03 K/µL. These ranges do not replace your lab's own ranges and do not apply to people who are not Duffy null.

Key takeaways:

  • One in four healthy Duffy-null adults had an ANC below 2.0, and between a quarter and half of the children, depending on age, were below 1.5, the usual cutoff for neutropenia.
  • Results held regardless of the blood analyzer, clinic setting, or how the sample was drawn.
  • These are the first published Duffy-null ranges for children; data for babies under 6 months are not yet available.

A companion paper from the same group lays out a roadmap for hospitals and labs: test for Duffy status, record it in the health record, update lab software, and educate clinicians and patients.

Why it matters: fewer unnecessary tests

When standard ranges are used, a healthy Duffy-null person can be labeled neutropenic. According to ASH and the published research, that mislabel can lead to repeat testing, referrals, and even bone marrow biopsies, along with delayed or reduced treatments and exclusion from clinical trials. One analysis of phase 3 trials for the five most common cancers in the US and UK found that about three in four excluded patients whose ANC was normal for a Duffy-null person, and that more than half of standard cancer drug regimens called for dose changes at those levels.

The issue is not limited to the US. A 2026 study in Blood with participants from Namibia, Saudi Arabia, the UK, and the US found very similar Duffy-null ranges across countries. Local lab ranges wrongly classified roughly a quarter to half of these healthy people as neutropenic, and among Duffy-null participants, race did not change the results. In other words, the blood group drives the lower count, not race itself, which is why experts recommend testing rather than guessing.

What the study does not say

  • A low count is not always due to Duffy null. A new or very low ANC, or one that comes with infections, mouth sores, anemia, or low platelets, still needs a full workup.
  • Ancestry alone cannot confirm the trait; only a Duffy blood test can.
  • The ranges describe healthy people. They do not set the thresholds your oncology team uses during chemotherapy.

Recent advances

Research on this topic has moved fast in three years. In 2023, a primary care study found that two in three Black adults tested were Duffy null and had clearly lower neutrophil counts, and its authors called for dedicated ranges. In 2024, researchers showed how often cancer trials excluded these patients. In 2025, a large genetic study confirmed that the trait carries no disease risk and is also found in people with Middle Eastern, Hispanic, or mixed ancestry. In 2026, a multinational study and the two new Blood Advances papers delivered adult and, for the first time, pediatric ranges. What it means for you: a slightly low, stable neutrophil count with no symptoms may be completely normal if you are Duffy null, and a simple blood test can tell you whether you are.

Which tests can monitor or screen for this?

  • Complete blood count (CBC) with differential: counts white blood cells, neutrophils, red blood cells, and platelets. A low neutrophil count with normal red cells and platelets is the typical DANC pattern.
  • Repeat CBCs over time: a count that stays stable for months, without symptoms, is reassuring.
  • Duffy red blood cell phenotyping: a blood test that looks for the Fy(a) and Fy(b) antigens, already used in blood banks. When both are absent, you are Duffy null. A genetic test for the rs2814778 variant is another option.
  • Further tests your doctor may order if the picture is not typical: medication review, viral tests, autoimmune markers, or a hematology referral.

To learn more about other causes, see our guide to low absolute neutrophils and our overview of the white blood cell count.

When to see a doctor

  • Right away, or call 911, if you have a fever and a known low neutrophil count, especially during cancer treatment.
  • Promptly if the drop is new or very low (below 0.5 ×10⁹/L), or comes with anemia or low platelets.
  • If you have frequent infections, recurring mouth sores, or bleeding gums.
  • If several blood tests have shown low neutrophils: ask whether Duffy testing makes sense and whether the result can be recorded in your chart.

Glossary

  • Neutrophils: the most common white blood cells, the body's first line of defense against bacteria.
  • Absolute neutrophil count (ANC): the number of neutrophils in a given volume of blood.
  • Neutropenia: an ANC below the lab's lower limit, usually 1.5 ×10⁹/L in adults.
  • Duffy null, Fy(a-b-): absence of the Duffy antigen on red blood cells, a harmless inherited trait.
  • DANC: Duffy null-associated neutrophil count, the current name for the trait's lower but healthy counts.
  • Reference range: the interval that contains the results of 95% of healthy people in a given population.
  • Phenotyping: a lab test that identifies which blood group antigens are present on red blood cells.

Frequently asked questions

Is Duffy null-associated neutrophil count dangerous?

No. Research shows it does not raise the risk of infection or any disease. It matters only because it can be mistaken for true neutropenia and lead to unnecessary tests.

How do I find out if I am Duffy null?

Through a blood test that checks for the Duffy antigens on your red cells, or a genetic test. Your doctor may order it if your neutrophils are repeatedly low with no other explanation.

Will my lab report start using the new ranges?

Not automatically. Each lab sets its own ranges, and adopting Duffy-null ranges requires knowing your Duffy status. ASH and the study authors are encouraging hospitals and labs to make that change.

My child has low neutrophils. Is it Duffy null?

Not necessarily. In children, viral infections often cause a temporary drop. A repeat test and, if needed, a specialist opinion can tell the difference.

Does Duffy status matter for chemotherapy?

It can, because many regimens adjust doses based on neutrophil counts. Tell your oncology team your Duffy status; they decide which thresholds apply.

Sources

Other articles

Understand your own blood test results with AI DiagMe

Seeing a low neutrophil or white blood cell count on your CBC? AI DiagMe helps you understand each value in minutes, in plain language, so you can have a better conversation with your doctor.

Editorial team

  • AI DiagMe

    Author

    The AI DiagMe team brings together physicians, clinical specialists, and medical editors. Our articles are written by health communication professionals and then reviewed and validated by the physicians of our scientific committee, composed of practicing hospital physicians in specialties such as hematology, endocrinology, and general medicine. Julien Priour, who leads the editorial mission, holds an MBA from HEC Paris and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). Each piece of content is based on current clinical guidelines and peer-reviewed medical publications.

    Email Website
  • Julien Priour

    Edited by

    Co-founder and CEO of AI DiagMe · Senior medical editor · HEC Paris graduate

    Julien Priour is a senior medical editor at AI DiagMe, where he oversees the editorial line and the fact-checking process. A graduate of HEC Paris, he has 3 years of experience in health publishing and was trained in scientific writing and publishing by the French National Research Institute for Sustainable Development (IRD, FUN-MOOC, 2026). He makes sure that every article follows current medical guidelines and is reviewed and validated by a physician from the scientific and ethics committee. He sets the sourcing standards (HAS, Ameli, INSERM…) and the review standards applied across the entire site.

    Email LinkedIn
  • Dr. Claude Tchonko

    Medically reviewed by

    Dr. Claude Tchonko is a hematologist, in practice since 2013, currently working at Clinique Mas de Rochet (Castelnau-le-Lez, France). With an international background, he specializes in the management of hematologic malignancies (leukemias, lymphomas, myelomas), with particular expertise in autologous stem cell transplantation, CAR-T cell therapy and the optimization of care pathways in onco-hematology.

    Author of a reference work, “Lymphoid Hematologic Malignancies in Mali”, he combines clinical practice with active involvement in projects developing technology solutions for healthcare.

    He holds a State Doctorate in Medicine (Faculty of Medicine of Bamako, 2006) and completed his training with a Certificate of Specialized Studies in Bioclinical Hematology (Abidjan-Cocody, 2010) and several university diplomas: a DFMS in Hematology and an inter-university diploma (DIU) in Onco-Hematological Cytogenetics (Grenoble), as well as a university diploma (DU) in major sickle cell disease (UPEC).

    Dr. Claude Tchonko LinkedIn

Related Posts

Coming Soon